MDNA logo

Medicenna Therapeutics (MDNA) Company Overview

Profile

Full Name:

Medicenna Therapeutics Corp.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Canada

IPO:

November 13, 2017

Indexes:

Not included

Website:

http://www.medicenna.com

Description:

Medicenna Therapeutics Corp., an immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer and other diseases. It develops MDNA55, an interleukin- 4 (IL-4) EC for the treatment of recurrent glioblastoma, as well as for brain tumors. The company also develops MDNA11, an enhanced version of IL-2 to activate and proliferate the immune cells needed to fight cancer; MDNA209, an IL-2 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host disease; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; and MDNA132, an IL-13 Superkine for solid tumors. In addition, it provides BiSKITs platform to develop designer Superkines by fusing them to other proteins, antibodies, cytokines, or other Superkines. The company is headquartered in Toronto, Canada.

Key Details

Price

-

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

-

Annual EPS

-$0.12(+63.88% YoY)

PE Ratio

-

Annual ROE

-34.86%

Annual Debt To Equity

0.00

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 3, 2023

Recent annual earnings:

Jun 27, 2023
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jun 1, 21 HC Wainwright & Co.
Buy
Dec 18, 20 Oppenheimer
Outperform
Dec 17, 20 Oppenheimer
Outperform
Nov 25, 20 HC Wainwright & Co.
Buy
Sep 10, 20 HC Wainwright & Co.
Buy

Screeners with MDNA included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

-
MDNA price value is unknown

Price All-time High

$5.97
MDNA price is currently at an all-time high

Price Analysts Target

-
MDNA price consensus analysts' forecast is unknown

Price Most Recent Change

-
MDNA price change on Jan 1, 1 is unknown

Price YTD Change

-
MDNA price ytd change is unknown

Price 3-Year Change

-
MDNA price 3-year change is unknown

Market cap

Market Cap

-
MDNA market capitalization value is unknown

Market Cap 3-Year Change

-
MDNA market capitalization 3-year change is unknown

Market Cap All-time High

$292.52 M
MDNA market capitalization is currently at an all-time high

Market Cap Sector Rank

-
MDNA market capitalization is unknown

Technical

Beta

-
MDNA beta value is unknown

200-day SMA

-
MDNA SMA 200 is unknown

14-day RSI

-
MDNA 14-day relative strength index value is unknown

30-day Relative Volume

-
MDNA 30-day relative volume value is unknown

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

-
MDNA annual revenue value is unknown

Annual Revenue Analysts Estimate

$360.00 K
MDNA annual revenue is currently equal to the consensus analysts' forecast

Annual Revenue 1-Year Change

-
MDNA annual revenue 1-year change is unknown

Annual Revenue Sector Rank

-
MDNA annual revenue is unknown

Profit

Annual Gross Profit

-
MDNA annual gross profit value is unknown

Annual Gross Margin

-
MDNA annual gross profit margin value is unknown

Annual Operating Profit

-$12.33 M
MDNA annual operating income is -$12.33 million

Annual Operating Margin

-
MDNA annual operating profit margin value is unknown

Annual Net Income

-$7.60 M
MDNA annual net profit is -$7.60 million

Annual Net Margin

-
MDNA annual net profit margin value is unknown

EPS

Annual EPS

-$0.12
MDNA annual earnings per share is -$0.12

Annual EPS Analysts Estimate

-$0.17
MDNA annual earnings per share is currently -28.82% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+63.88%
MDNA annual earnings per share is up +63.88% year-on-year

Annual EPS Sector Rank

-
MDNA annual earnings per share is unknown

ROA & ROE

Annual ROA

-28.21%
MDNA annual return on assets is -28.21%

Annual ROE

-34.86%
MDNA annual return on equity is -34.86%

EBIT & EBITDA

Annual EBIT

-$12.33 M
MDNA annual earnings before interest & taxes is -$12.33 million

Annual EBITDA

-$12.33 M
MDNA annual EBITDA is -$12.33 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
MDNA price to earnings ratio value is unknown

PE Ratio Sector Rank

-
MDNA price to earnings ratio is unknown

PB Ratio

PB Ratio

-
MDNA price to book ratio value is unknown

PB Ratio Sector Rank

-
MDNA price to book ratio is unknown

PS Ratio

PS Ratio

-
MDNA price to sales ratio value is unknown

PS Ratio Sector Rank

-
MDNA price to sales ratio is unknown

Enterprise value

Enterprise Value

-
MDNA enterprise value value is unknown

Enterprise Value Sector Rank

-
MDNA enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
MDNA EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
MDNA EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

9.57
MDNA annual current ratio is 9.57

Annual Quick Ratio

-
MDNA annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.00
MDNA annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
MDNA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
MDNA piotroski f-score value is unknown

Altman Z-Score

-
MDNA altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$26.95 M
MDNA annual total assets is $26.95 million

Annual Non Current Assets

$45.10 K
MDNA annual long term assets is $45.10 thousand

Annual Current Assets

$26.90 M
MDNA annual total current assets is $26.90 million

Annual Cash & Cash Equivalents

$24.84 M
MDNA annual cash & cash equivalents is $24.84 million

Equity

Annual Book Value

$21.80 M
MDNA annual book value is $21.80 million

Annual Working Capital

$24.09 M
MDNA annual working capital is $24.09 million

Liabilities

Annual Total Liabilities

$5.15 M
MDNA annual total liabilities is $5.15 million

Annual Total Long Term Liabilities

$2.34 M
MDNA annual total long term liabilities is $2.34 million

Annual Current Liabilities

$2.81 M
MDNA annual total current liabilities is $2.81 million

Annual Accounts Payable

$1.20 M
MDNA annual accounts payable is $1.20 million

Debt

Annual Total Debt

$0.00
MDNA annual total debt is $0.00

Annual Total Debt 1-Year Change

0%
MDNA {parameterFullLabel} has remained unchanged year-on-year

Annual Long Term Debt

-
MDNA annual long term debt value is unknown

Annual Short Term Debt

-
MDNA annual short term debt value is unknown

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$12.33 M
MDNA annual total expenses is $12.33 million

Annual Operating Expenses

$12.33 M
MDNA annual total operating expenses is $12.33 million

Annual Cost Of Goods Sold

-
MDNA annual cost of goods sold value is unknown

Annual SGA

$5.29 M
MDNA annual SGA is $5.29 million

Annual D&A

$3000.00
MDNA annual depreciation & amortization is $3000.00

Annual Interest Expense

-
MDNA annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$9.57 M
MDNA annual cash flow from operations is -$9.57 million

Annual CFO 1-Year Change

+49.11%
MDNA annual cash flow from operations is up +49.11% year-on-year

Annual CFI

$0.00
MDNA annual cash flow from investing activities is $0.00

Annual CFI 1-Year Change

-100%
MDNA annual cash flow from investing activities is down -100% year-on-year

Annual CFF

$18.73 M
MDNA annual cash flow from financing activities is $18.73 million

Annual CFF 1-Year Change

+505.48%
MDNA annual cash flow from financing activities is up +505.48% year-on-year

Free CashFlow

Annual FCF

-$9.57 M
MDNA annual free cash flow is -$9.57 million

Annual FCF 1-Year Change

+49.11%
MDNA annual free cash flow is up +49.11% year-on-year

CAPEX

Annual CAPEX

-
MDNA annual capital expenditures value is unknown

Annual CAPEX 1-Year Change

-
MDNA annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

FAQ

  • What is the ticker symbol for Medicenna Therapeutics?
  • Does Medicenna Therapeutics pay dividends?
  • What sector is Medicenna Therapeutics in?
  • What industry is Medicenna Therapeutics in?
  • What country is Medicenna Therapeutics based in?
  • When did Medicenna Therapeutics go public?
  • Is Medicenna Therapeutics in the S&P 500?
  • Is Medicenna Therapeutics in the NASDAQ 100?
  • Is Medicenna Therapeutics in the Dow Jones?
  • When was Medicenna Therapeutics's last earnings report?
  • When does Medicenna Therapeutics report earnings?

What is the ticker symbol for Medicenna Therapeutics?

The ticker symbol for Medicenna Therapeutics is NASDAQ:MDNA

Does Medicenna Therapeutics pay dividends?

No, Medicenna Therapeutics does not pay dividends

What sector is Medicenna Therapeutics in?

Medicenna Therapeutics is in the Healthcare sector

What industry is Medicenna Therapeutics in?

Medicenna Therapeutics is in the Biotechnology industry

What country is Medicenna Therapeutics based in?

Medicenna Therapeutics is headquartered in Canada

When did Medicenna Therapeutics go public?

Medicenna Therapeutics's initial public offering (IPO) was on November 13, 2017

Is Medicenna Therapeutics in the S&P 500?

No, Medicenna Therapeutics is not included in the S&P 500 index

Is Medicenna Therapeutics in the NASDAQ 100?

No, Medicenna Therapeutics is not included in the NASDAQ 100 index

Is Medicenna Therapeutics in the Dow Jones?

No, Medicenna Therapeutics is not included in the Dow Jones index

When was Medicenna Therapeutics's last earnings report?

Medicenna Therapeutics's most recent earnings report was on Nov 3, 2023

When does Medicenna Therapeutics report earnings?

The date for Medicenna Therapeutics's next earnings report has not been announced yet